Product Information
FENOFIBRATE 134 MG CAPSULE is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.1141 per EA under NDC 42858013401. Its NADAC has been published 468 times since Jul 12, 2017.
Strength
134 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858013401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA075753On Market Since
6/1/2017
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 134 MG CAPSULE has been published 468 times since Jul 12, 2017, and over the history we have for it it has declined 88.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1141 per EA |
|---|---|
| All-time high | $1.0421 (Aug 16, 2017) |
| All-time low | $0.1020 (Nov 20, 2024) |
| 52-week high | $0.1391 |
| 52-week low | $0.1101 |
| Median price | $0.1760 |
| Average price | $0.2829 |
| Largest weekly change | +38.9% (Sep 23, 2020) |
| Weeks tracked | 468 |
| Tracking since | Jul 12, 2017 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 134 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 134 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $0.1141 per EA (NDC 42858013401), effective Jun 24, 2026.
How has the price of FENOFIBRATE 134 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 134 MG CAPSULE has declined 88.8%. It has been tracked across 468 weekly CMS publications since Jul 12, 2017.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 134 MG CAPSULE?
Since Jul 12, 2017, the NADAC for FENOFIBRATE 134 MG CAPSULE has ranged from a low of $0.1020 (Nov 20, 2024) to a high of $1.0421 (Aug 16, 2017), with a median of $0.1760 per EA.
Are there cheaper alternatives to FENOFIBRATE 134 MG CAPSULE?
5 NADAC-published products share the same active ingredient, strength, and dosage form as FENOFIBRATE 134 MG CAPSULE, but none are currently priced below it.
Who manufactures FENOFIBRATE 134 MG CAPSULE?
FENOFIBRATE 134 MG CAPSULE (NDC 42858013401) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.
Related Drugs
Same classification